Q264 · For a manufacturer of proprietary Chinese…

Q264 · Category F: Fees, Budget and Financial Planning (Q251-Q300)

Establishing a Chinese medicine factory that complies with Good Manufacturing Practice (GMP) is a long-term strategic investment. The payback period cannot be generalised, but is usually measured in years. Its length depends on several changing factors: 1. “Product portfolio and market positioning”: whether your medicines have exclusive patents, strong brand appeal or clear market demand. 2. “Sales channels and network”: whether you have an effective distribution network to bring products to market quickly. 3. “Production efficiency and cost control”: the level of production-line automation, yield and raw-material purchasing costs directly affect profit margins. 4. “Pricing strategy”: whether product prices can generate sufficient returns after covering high fixed-asset depreciation and operating costs.

📘 Regulatory basis

The Chinese Medicine Council of Hong Kong requires manufacturers of proprietary Chinese medicines to comply with PIC/S GMP standards. This entails substantial upfront capital expenditure on factory design, equipment procurement, validation and staff training. Such expenditure is a major cost that must be taken into account when calculating the return on investment.

📗 Drew Tang's recommendations

For new entrants, we generally do not recommend building your own GMP facility as a first step. A more prudent strategy is to begin with a contract manufacturing organisation (CMO) model, using the capacity of an existing licensed facility to produce your products and test the market response. Once sales and the brand reach a certain scale, you can consider investing in your own facility, thereby minimising initial risk.

📕 Risk notice

The greatest risk of investing in a GMP facility is market risk. If, after substantial investment in building the facility, the products fail to meet expected sales targets due to a lack of competitiveness or a poor market strategy, this major fixed-asset investment may never be recovered. This is a typical capital-intensive industry, so decisions must be made with extreme care.

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

For a manufacturer of proprietary Chinese medicines, approximately how long is the payback period for establishing a GMP-compliant facility?

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang